[Hormonal therapy of the advanced breast cancer ]. 1982

R Gürtler, and M L Matthes, and S Tanneberger

In this review several possibilities of an individualized hormonal therapy of the advanced breast cancer are discussed. Tumors selected for hormonal therapy on the basis of a positive estrogen receptor respond to endocrine therapy at nearly twice the rate of those chosen by clinical criteria alone. The overall response can be predicted with an accuracy of about 75 per cent. Furthermore clinical tests like short time treatment with L-dopa or testosterone are liable for many subjective mistakes. If the multivalent analyse of various prognostic criteria will be better for predicting the mistakes. If the multivalent analyse of various prognostic criteria will be better for predicting the hormone sensitivity is up to now unknown. The paper gives several guides for the ablative and additive hormonal therapies.

UI MeSH Term Description Entries
D007016 Hypophysectomy Surgical removal or destruction of the hypophysis, or pituitary gland. (Dorland, 28th ed) Hypophysectomies
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002369 Castration Surgical removal or artificial destruction of gonads. Gonadectomy,Castrations,Gonadectomies
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D005260 Female Females
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Gürtler, and M L Matthes, and S Tanneberger
December 1949, Der Krebsarzt,
R Gürtler, and M L Matthes, and S Tanneberger
April 2007, Hematology/oncology clinics of North America,
R Gürtler, and M L Matthes, and S Tanneberger
May 1981, Cancer,
R Gürtler, and M L Matthes, and S Tanneberger
December 1990, Seminars in oncology,
R Gürtler, and M L Matthes, and S Tanneberger
January 1992, Oncology,
R Gürtler, and M L Matthes, and S Tanneberger
January 2004, The breast journal,
R Gürtler, and M L Matthes, and S Tanneberger
January 1977, Progress in clinical and biological research,
R Gürtler, and M L Matthes, and S Tanneberger
August 2000, Seminars in oncology nursing,
R Gürtler, and M L Matthes, and S Tanneberger
June 1992, Seminars in oncology,
R Gürtler, and M L Matthes, and S Tanneberger
January 2002, Clinical therapeutics,
Copied contents to your clipboard!